| Address: | 1525 Clifton Rd, Atlanta, GA 30322, USA |
|---|---|
| Postal code: | 30322 |
| Phone: | (404) 778-3333 |
| Website: | http://www.emoryhealthcare.org/physicians/a/arbiser-jack.html |
There are no reviews yet!
You can review this Business and help others by leaving a comment. If you want to share your thoughts about Jack L. Arbiser, MD, use the form below and your opinion, advice or comment will appear in this space.
Jack L. Arbiser, MD, PhD. Laura D. Aspey, MD, MPH. Travis W. Blalock, MD. S. Wright Caughman, MD. Justin T. Cheeley, MD. Sarah Chisolm, MD. Salma Faghri de la Feld, MD. Moses D. Elam, MD.
Jack L. Arbiser, MD, PhD. Department of Dermatology, Emory University. School of Medicine, Atlanta, Georgia. Health Administration Hospital Merit Award. Conflicts of interest: None declared. Correspondence to: Jack L. Arbiser, MD, PhD
Correspondence: Jack L. Arbiser, MD, PhD, Depart-ment of Dermatology, Emory University School of Medi-cine, WMB 5309, 1639 Pierce Dr, Atlanta, GA Author Contributions: Dr Arbiser had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of...
Jack L.. Arbiser, MD, PhD Jack L. Arbiser, MD, PhD is a Professor in the Department of Dermatology and Winship Cancer Institute at Emory University. Dr. Arbiser's research focuses on the regulation of angiogenesis and tumorigenesis by signal transduction pathways.
Correspondence: Jack L. Arbiser, MD, PhD, Emory Uni-versity School of Medicine, WMB 5309, 1639 Pierce Dr, Atlanta, GA 30322 1. Arbiser JL. Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of syn-ergy in...
Address correspondence to: Jack L. Arbiser, MD, PhD, Department of Dermatology, Emory University School of Medicine, WMB 5309, 1639 Pierce Arbiser JL: Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: Evidence of predictable and reproducible patterns of...
A team of Emory scientists led by Jack L. Arbiser, MD, PhD, found that the signaling pathway called mitogen activated protein kinase (MAP kinase) is abnormally turned on in melanoma, particularly in its early stages. The investigators studied levels of activated MAP kinase in 131 tissue samples from...
University School of Medicine and published in the melanoma cells into highly invasive tumors via. March issue of the Journal of Clinical Investigation. reactive oxygen pathways," says Dr. Arbiser. "This. Senior author is Jack L. Arbiser, MD, PhD, and could provide us with promising targets for anti